by the combination of two (ROSC+Ola, ROSC+IR, Ola+IR) or all three treatments (ROSC+Ola+IR). After irradiation cells were incubated for 24 h before medium was changed and colonies were allowed to grow until equal size was achieved. After treatment with roscovitine or olaparib alone surviving fraction was corrected for the plating efficiency; irradiated samples were additionally corrected for the effects of the inhibitors alone. Mean values ± SEM.
Supplementary Figure 5: Association between the surviving fraction (SF) and the number of residual γH2AX foci measured for UM-SCC-3 (HPV neg.), UD-SCC-2 and UM-SCC-47 (HPV pos.) cell lines after irradiation alone or in combination with roscovitine and/or olaparib.
For cell survival, data were taken from Figure 5 and supplement Figure S4 and for residual γH2AX foci from Figure 4 . Data could be described by one single correlation demonstrating that independent of the treatment used a change in survival is associated with a respective variation in the number of residual γH2AX foci. These data demonstrates that the change in survival measured after the different treatments are mainly achieved by an interference with DSB repair capacity. Mean values ± SEM.
